Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
LCTB-21 by Perha Pharmaceuticals for Alzheimer's Disease: Likelihood of Approval
LCTB-21 is under clinical development by Perha Pharmaceuticals and currently in Phase I for Alzheimer's Disease. According to GlobalData, Phase...
Data Insights
LCTB-21 by Perha Pharmaceuticals for Down Syndrome: Likelihood of Approval
LCTB-21 is under clinical development by Perha Pharmaceuticals and currently in Phase I for Down Syndrome. According to GlobalData, Phase...